{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T19:27:32Z","timestamp":1769542052271,"version":"3.49.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Fatty liver (FL) is a common comorbidity that has been associated with adverse clinical outcomes in various liver diseases. However, its impact on the prognosis of acute hepatitis B (AHB) remains unclear. This study aimed to evaluate the influence of FL on liver-related outcomes among hospitalized patients with AHB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on hospitalized patients diagnosed with AHB from January 1, 2010, to December 30, 2023. Demographic and clinical data were collected, and patients were categorized into AHB with FL (AHB-FL) and AHB without FL (AHB-no FL) groups based on imaging and laboratory examinations. Multivariate regression models were utilized to investigate the association between FL and liver-related outcomes, including acute liver failure (ALF), hepatitis B surface antigen (HBsAg) loss, and seroconversion. Kaplan-Meier analysis was performed to assess differences in time to HBsAg loss and seroconversion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 200 eligible patients were included, with 29 (14.5%) in the AHB-FL group and 171 (85.5%) in the AHB-no FL group. The incidence of ALF was significantly higher in the AHB-FL group (34.5% vs. 15.8%, P\u00a0=\u00a00.02). No significant differences were observed in rates of HBsAg loss (75.9% vs. 82.5%, P\u00a0=\u00a00.40) or seroconversion (44.4% vs. 53.1%, P\u00a0=\u00a00.40) between the two groups. Kaplan-Meier analysis indicated comparable times to HBsAg loss (P\u00a0=\u00a00.07) and seroconversion (P\u00a0=\u00a00.43). Multivariable analysis confirmed FL as an independent risk factor for ALF (OR 4.61, 95% CI 1.26\u201316.86; P\u00a0=\u00a00.02), but not for HBsAg loss (HR 1.60, 95% CI 0.92\u20132.78; P\u00a0=\u00a00.10) or seroconversion (HR 1.69, 95% CI 0.80\u20133.57; P\u00a0=\u00a00.17). Subgroup analysis indicated a stronger association between FL and ALF in rural patients (P interaction=0.02), suggesting regional differences may affect clinical risks and management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>FL constitutes a robust and independent determinant of ALF in AHB patients, sustained after rigorous adjustment for confounding factors. This evidence highlights a specific metabolic aggravation of liver injury, mandating the integration of FL screening into early risk stratification and management protocols.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcimb.2026.1712115","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:26Z","timestamp":1769495966000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between fatty liver and risk of liver failure in patients with acute hepatitis B: a retrospective cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiao-hao","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-nan","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Children\u2019s Hospital of Chongqing Medical University","place":["Chongqing, China"]},{"name":"National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-li","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-wen","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Zhong","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Key Laboratory of Molecular Biology for Infectious Diseases, Ministry of Education, Institute for Viral Hepatitis, The Second Affiliated Hospital, Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.redox.2018.01.009","article-title":"Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: Current and innovative therapeutic approaches","volume":"15","author":"Borrelli","year":"2018","journal-title":"Redox Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"a024935","DOI":"10.1101\/cshperspect.a024935","article-title":"Viral hepatitis B: clinical and epidemiological characteristics","volume":"4","author":"Burns","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: A meta-analysis and systematic review of 10 739\u2013607 individuals","volume":"107","author":"Chan","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s12072-024-10711-4","article-title":"Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier","volume":"18","author":"Choudhury","year":"2024","journal-title":"Hepatol. Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","article-title":"Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis","volume":"125","author":"Feldstein","year":"2003","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coi.2015.06.016","article-title":"Host-virus interactions in hepatitis B virus infection","volume":"36","author":"Guidotti","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the prevalence of metabolic syndrome in the United States, 2011-2016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41572-025-00599-1","article-title":"Metabolic dysfunction-associated steatotic liver disease in adults","volume":"11","author":"Huang","year":"2025","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s12072-023-10545-6","article-title":"Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B","volume":"17","author":"Huang","year":"2023","journal-title":"Hepatol. Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3350\/cmh.2022.0422","article-title":"Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives","volume":"29","author":"Huang","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","volume":"22","author":"Iannacone","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.medj.2024.07.013","article-title":"Multisystem health comorbidity networks of metabolic dysfunction-associated steatotic liver disease","volume":"5","author":"Jiang","year":"2024","journal-title":"Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"G77","DOI":"10.1152\/ajpgi.00301.2011","article-title":"Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis","volume":"302","author":"Kakisaka","year":"2012","journal-title":"Am. J. Physiol. Gastrointest Liver Physiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/apt.16706","article-title":"Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver","volume":"55","author":"Kim","year":"2022","journal-title":"Aliment Pharmacol. Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1001\/jama.2023.17935","article-title":"Diagnosis and management of nonalcoholic fatty liver disease","volume":"330","author":"Leung","year":"2023","journal-title":"JAMA"},{"key":"B16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/infdis\/jiaa739","article-title":"Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B","volume":"224","author":"Li","year":"2021","journal-title":"J. Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/v14061180","article-title":"Burden and trends of acute viral hepatitis in asia from 1990 to 2019","volume":"14","author":"Liu","year":"2022","journal-title":"Viruses"},{"key":"B18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0140-6736(24)00693-7","article-title":"Acute liver failure","volume":"404","author":"Maiwall","year":"2024","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.jhep.2020.05.040","article-title":"Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B","volume":"73","author":"Mak","year":"2020","journal-title":"J. Hepatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12072-021-10218-2","article-title":"Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection","volume":"15","author":"Mak","year":"2021","journal-title":"Hepatol. Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/hep.32792","article-title":"Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis","volume":"77","author":"Mao","year":"2023","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41575-020-0342-4","article-title":"Liver regeneration: biological and pathological mechanisms and implications","volume":"18","author":"Michalopoulos","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1002\/hep.32228","article-title":"Global burden of NAFLD and chronic liver disease among adolescents and young adults","volume":"75","author":"Paik","year":"2022","journal-title":"Hepatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jacasi.2023.02.007","article-title":"20-year trends in metabolic syndrome among korean adults from 2001 to 2020","volume":"3","author":"Park","year":"2023","journal-title":"JACC Asia"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-037473","article-title":"Systematic review of the global epidemiology of viral-induced acute liver failure","volume":"10","author":"Patterson","year":"2020","journal-title":"BMJ Open"},{"key":"B26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12967-023-04294-1","article-title":"Intrahepatic macrophage reprogramming associated with lipid metabolism in hepatitis B virus-related acute-on-chronic liver failure","volume":"21","author":"Peng","year":"2023","journal-title":"J. Transl. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol. Int."},{"key":"B28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41575-018-0009-6","article-title":"Triggering and resolution of inflammation in NASH","volume":"15","author":"Schuster","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.842088","article-title":"Secular trends of acute viral hepatitis incidence and mortality in China, 1990 to 2019 and its prediction to 2030: the global burden of disease study 2019","volume":"9","author":"Su","year":"2022","journal-title":"Front. Med. (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.jhepr.2021.100398","article-title":"Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV","volume":"4","author":"Vanwolleghem","year":"2022","journal-title":"JHEP Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3350\/cmh.2023.0004","article-title":"Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis","volume":"29","author":"Wong","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"B32","article-title":"WHO, Hepatitis B","volume-title":"Fact Sheet","year":"2024"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1111\/liv.15252","article-title":"Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia","volume":"42","author":"Yang","year":"2022","journal-title":"Liver Int."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000196","article-title":"Incidence, factors, and patient-level data for spontaneous HBsAg seroclearance: A cohort study of 11,264 patients","volume":"11","author":"Yeo","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian perspective on NAFLD-associated HCC","volume":"76","author":"Yip","year":"2022","journal-title":"J. Hepatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jhep.2021.04.035","article-title":"Global burden of acute viral hepatitis and its association with socioeconomic development status, 1990-2019","volume":"75","author":"Zeng","year":"2021","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jhep.2024.08.024","article-title":"Frailty and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases","volume":"82","author":"Zhong","year":"2025","journal-title":"J. Hepatol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1712115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T06:39:26Z","timestamp":1769495966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2026.1712115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":37,"alternative-id":["10.3389\/fcimb.2026.1712115"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2026.1712115","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"article-number":"1712115"}}